Insulin Degludec + Liraglutide
Xultophy 100/3.6
Half-life
25 hr
Time to Peak
10 hr
Steady State
~6 days
Dose Range
10–50 units
Frequency
Daily
Overview
Once-daily injectable combination of basal insulin degludec and GLP-1 receptor agonist liraglutide for type 2 diabetes. Can be administered at any time of day, independent of meals.
Mechanism of Action
Fixed-ratio combination of insulin degludec (100 units/mL) and liraglutide (3.6 mg/mL) in a single pen. Ultra-long-acting basal insulin plus daily GLP-1 agonist.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Subcutaneous (SubQ) | 10–50 units | 25 hr | 10 hr | Daily |
Storage & Handling
2-8C — Refrigerate before first use. After first use: room temp (up to 30C) or refrigerated for up to 21 days. Do not freeze.
Used in Regimens
Insulin Degludec + Liraglutide is not currently part of any catalog regimen.
Data Sources
- FDA Label Xultophy FDA Prescribing Information
Related Tools
Track Insulin Degludec + Liraglutide with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.